AI assistant
Sending…
USBC, Inc. — Director's Dealing 2022
May 31, 2022
33069_dirs_2022-05-31_0c187a6e-51a5-4b00-8f21-28656ff5beb8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: KNOW LABS, INC. (KNWN)
CIK: 0001074828
Period of Report: 2022-05-20
Reporting Person: Trautwein Leonardo Mouta (Chief Marketing Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3980 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $2.04 | 2026-02-04 | Common Stock (200000) | Direct | |
| Option to Purchase Common Stock | $2.35 | 2026-02-09 | Common Stock (100000) | Direct | |
| Option to Purchase Common Stock | $2.09 | 2026-12-16 | Common Stock (100000) | Direct | |
| Option to Purchase Common Stock | $1.48 | 2027-05-20 | Common Stock (600000) | Direct |
Footnotes
F1: Options vest quarterly over four years. No vesting during first 6 months.
F2: Options vest upon FDA approval
F3: Options vest quarterly over four years.
More from USBC, Inc.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 26
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Jan 26